CVE-2026-59667: Cross-Site Scripting Vulnerability
Source GCVE Database
Not known to be exploited · CVSS 4.8 Medium : upgrade to Abril patch "20260402" when convenient.
Data as of 15 Nov 2026, 20:25 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 21% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in Abril patch "20260402"
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 2 Oct 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 15 Nov 2026.
What to do
Upgrade Repasat application to Abril patch "20260402".
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| RepasatRepasat application | Affected
| Fixed in
|
AI-suggested
In the absence of an official fix, users should exercise caution when interacting with untrusted content and consider implementing web application firewall rules or input validation as temporary mitigations.
Description
A Cross-Site Scripting (XSS) vulnerability exists in the Repasat application affecting the 'nomTamano' parameter at the '/es/companysizemployees/update' endpoint. This vulnerability could allow an attacker to execute arbitrary code in a victim's browser by tricking the user. The vulnerability is rated medium severity.